© 2006 Girindus
Solvay Organics
®
Oligonucleotide Manufacturing at Girindus
1
© 2009
1
®
Outline
Major Classes of Oligonucleotide Therapeutics Solid Phase Synthesis of Oligonucleotides
Synthesis Cycle Critical Raw Materials
Solvay Organics
3 Manufacturing Trains for Oligonucleotide Synthesis
Train 1: AKTA 100 DNA-Synthesizer; AKTA Purifier Train 2: OP400 DNA-Synthesizer; BioProcess HPLC Skid Train 3: Technikrom 120 mmol Synthesizer and HPLC Skid Desalting and Freeze-Drying Equipment to Scale
2
© 2009
Antisense Therapeutics
Solvay Organics
®
Protein Synthesis in unaltered Cell
Central Dogma of Biology DNA Æ mRNA Æ Protein
3
© 2009
Principle of Action of Antisense Oligonucleotides
®
Solvay Organics
Antisense Strand hybridizes to targeted mRNA Blocks translation of message into protein Typical Modifications: 2’-O-Alkyl, LNA, Morpholinos, N3’,P5’Amidates, Gapmers, Conjugates, etc.
4
© 2009
®
Solvay Organics
Aptamers
Nucleic acid macromolecule that binds tightly to a protein target Linear sequence of nucleotides, typically 20-45 nucleotides long Chain of nucleotides forms intramolecular interactions and folds into a complex three-dimensional shape Typical modifications: Amino end modified for post-conjugation with PEG; DNA, RNA, 2’-OMe, thioates, L-isomers (Spiegelmers)
5
© 2009
®
Immunostimulatory Oligonucleotides
Solvay Organics
From Krieg, A. M. 2006. Nat.Rev.Drug Discov. 5:471-484.
Oligonucleotides containing unmethylated CpG motifs TLR9 agonists initiate both an innate and an adaptive immune response, generating cytotoxic T cells (CTLs) and disease-specific antibodies
6
Typical modifications: DNA thioates, spacer, 5’-3’, base modifications
© 2009
®
RNA Interference (siRNA)
Solvay Organics
From Nobel Price Committee of Physiology and Medicine
Nobel Prize winning Science Science Magazine: Breakthrough of the year 2002 Andrew Fire and Craig Mello - Nobel Prize 2006 Typical modifications: 2’-OMe, 2’-Fluoro, Thioates, Conjugates
7
© 2009
miRNA
Solvay Organics
®
miRNA
RISC mRNA
From RegulusRX.com
One miRNA regulates expression of multiple genes miRNAs function by preventing translation of mRNAs into proteins miRNA work as single strands, “bubbles” are important for function
8
© 2009
®
miRNA
Solvay Organics
miRNA anti miR
RISC
anti miR Therapeutics hybridize to miRNA inhibiting formation of miRNA / mRNA duplex (upregulation) miRNA Therapeutics are being incorporated into the RISC complex and forming a miRNA / mRNA duplex (downregulation, not shown)
9
Typical modifications: 2’-OMe, 2’-Fluoro, Thioates, DNA, LNA
© 2009
®
Girindus’ Extensive Oligo Manufacturing Experience
DNA, Phosphorodiesters And Phosphorothioates RNA, Phosphorodiesters And Phosphorothioates 2‘-modified RNA Duplex RNA (small interfering RNA or siRNA) Chimeras/Gapmers (DNA/RNA/LNA) Aptamers With Various Backbones Conjugates DNA/RNA With Modified Backbone Radiolabeling (14C, 3H)
Solvay Organics
10
© 2009
®
Solid Phase Synthesis Of Oligonucleotides
Starting Nucleoside on Solid Support
DMTO Base O DMT (yellow) O O Base O O O O R
1 1
Solvay Organics
+
R
1. Detritylation
CHCl2COOH HO O O R Cleavage Base1
R: OTBDMS (RNA) OCH3 (2'-OMe-RNA) H (DNA)
AcO
5'-OH-Oligomer
4. Capping
Chain Termination DMTO Base O O NCH2CH2CO P X O X=O S O NCH2CH2CO R O P O O O O R R Base1 O R Base O DMTO O
1 2
DMTO
Base O O P N R
2
2. Coupling
OCH2CH2CN
Base2
+ Ethylthio-tetrazole, Benzyl-mercapto-tetrazole or Dicyanoimidazole
3. Oxidation
4 synthetic steps per base (21-mer = 80 chemical reactions) No internal quality control until after cleavage and deprotection
11
© 2009
Key Raw Materials
Solvay Organics
®
Phosphoramidites:
NH-Bz N N DMTO O P NCCH2CH2O NiPr2 NCCH2CH2O R= H: deoxy adenosine R= OMe: 2'-OMe adenosine R= OTBDMS: adenosine O R N DMTO O P NiPr2 NCCH2CH2O R= H: deoxy cytidine R= OMe: 2'-OMe cytidine R= OTBDMS: cytidine O R N N NH-Ac N O DMTO O P NiPr2 NCCH2CH2O R= H: deoxy guanosine R= OMe: 2'-OMe guanosine R= OTBDMS: guanosine O R N N N O R' NH NH-iBu DMTO O P NiPr2 R= H, R'=Me: thymidine R= OMe, R'= H: 2'-OMe uridine R= OTBDMS, R'=Me: uridine O R N O NH O
Solid Supports:
CPG Si H N O H N O N H
B
DMTO O O O O R DMTO O O O R
B or
PS
N H
Abbreviations:
OCH3 O DMT: OCH3 Bz: Ac: O CH3 iBu: CH3 CH3
H3C CH3 Si TBDMS: H3C H3C CH3
O
12
© 2009
®
Solvay Organics
Critical and Non-Critical Impurities
Critical Impurities
Phosphitylation reagent and all other related P(III) impurities Different Isomers of Nucleoside Phosphoramidite Other P(III) compounds resulting from phosphitylated nucleoside impurities Water and all Alcohols (residual solvents)
Non-Critical Impurities
All Oxidized and Hydrolyzed P(III) impurities Non-alcohol residual solvents
13
© 2009
Quality of
1e+005
31P-NMR
1e+005
Spectra
Solvay Organics
®
1024 scans
0e+000 6e+004 4e+004 2e+004 0e+000 152.0 3e+004 2e+004 1e+004 0e+000 152.0 15000 10000 5000 0 152.0 5000 151.5 151.0 150.5 150.0 149.5 149.0 148.5 ppm 151.5 151.0 150.5 150.0 149.5 149.0 148.5 ppm 151.5 151.0 150.5 150.0 149.5 149.0 148.5 ppm 152.0 151.5 151.0 150.5 150.0 149.5 149.0 148.5 ppm
0e+000 6e+004 4e+004 2e+004 0e+000 35
3e+004
35
30
25
20
15
10
5
ppm
512 scans
30
25
20
15
10
5
ppm
256 scans
2e+004 1e+004 0e+000 35
15000
30
25
20
15
10
5
ppm
128 scans
10000 5000 0 35
5000
30
25
20
15
10
5
ppm
64 scans
0
0
14
152.0
151.5
151.0
150.5
150.0
149.5
149.0
148.5 ppm
35
30
25
20
15
10
5
ppm
© 2009
Quality of Spectra continued No. of
No. of Scans 1024 512 256 128 64 S/N ratio 6565 4691 3158 2343 1633 Purity 98.1% 97.8% 98.1% 98.0% 98.3% P(III) Impurities 0.82% 0.86% 0.62% 0.72% 0.41% P(III) Impurities 9 7 5 3 2 P(V) No. of P(V) Impurities Impurities 1.11% 6 1.33% 7 1.26% 6 1.31% 5 1.25% 5
31P-NMR
®
Solvay Organics
15
© 2009
Amidite Quality Differences by
1.0e+005
31P-NMR
Solvay Organics
®
P(III): 0.8%
1e+005
Manufacturer A, Lot A1, 2y 9m at 20 C P(V): 1.4%
45 40 35 30 25 20 15 10 5 0 ppm
5.0e+004
0e+000
0.0e+000 154 153 152 151 150 149 148 147 146 145 144 143 142 141 140 139 ppm
1.0e+005
P(III): 0.5%
1e+005
Manufacturer A, Lot A2, upon receipt P(V): 0.8%
45 40 35 30 25 20 15 10 5 0 ppm
5.0e+004
0e+000
0.0e+000 154 153 152 151 150 149 148 147 146 145 144 143 142 141 140 139 ppm
1.0e+005
P(III): 2.6%
1e+005 0e+000
Manufacturer A, Lot A3,, upon receipt P(V): 0.7%
45 40 35 30 25 20 15 10 5 0 ppm
5.0e+004
0.0e+000 154 153 152 151 150 149 148 147 146 145 144 143 142 141 140 139 ppm
1.0e+005
P(III): 0.8%
1e+005 0e+000
Manufacturer B, Lot B1, upon receipt P(V): 0.0%
45 40 35 30 25 20 15 10 5 0 ppm
5.0e+004
0.0e+000 154 153 152 151 150 149 148 147 146 145 144 143 142 141 140 139 ppm
16
© 2009
Amidite Quality Differences by HPLC
Solvay Organics
8 .2 4 7
®
8 .2 4 7
9 .1 4 5
0.40 0.35 0.30 0.25 A U 0.20 0.15 0.10 0.05 0.00 2.00 4.00 6.00 8.00
0.050
3 .3 9 5
9 .8 7 7
3 .6 9 1
8 .0 0 0
0.000
-0.010 2.00
3.00
4.00
5.00
6.00
7.00
8.00 Minutes
9.00
10.00
11.00
1 1 .1 7 6
0.010
7 .1 1 7 7 .2 1 5
2 .4 1 3
5 .2 2 9
5 .5 0 6
5 .7 1 1
6 .4 7 0
7 .7 8 2
1 0 .8 0 5
Lot A2 97.1%
0.040
0.030
A U
0.020
9 .1 4 5
12.00
13.00
14.00
15.00
10.00
1 0 .8 0 5 1 1 .1 7 6
12.00
3 .3 9 5 3 .6 9 1
7 .7 8 2 8 .0 0 0
7 .1 1 7 7 .2 1 5
5 .2 2 9 5 .5 0 6 5 .7 1 1
6 .4 7 0
2 .4 1 3
9 .8 7 7
14.00 16.00 Minutes
18.00
20.00
22.00
24.00
26.00
28.00
30.00
8 .2 8 5
9 .1 9 0
8 .2 8 5
0.50
0.040
0.40
A U
0.30
Lot A3 98.5%
5 .2 4 5 5 .5 2 3 5 .7 3 4 7 .1 2 2 7 .2 0 0 7 .8 1 2 6 .4 9 9
0.030
A U
0.020
5 .2 4 5
9 .9 2 9
1 0 .8 6 3
0.20
0.000
-0.010 2.00
3.00
4.00
5.00
6.00
7.00
8.00 Minutes
9.00
10.00
11.00
1 1 .2 3 8
0.010
5 .5 2 3 5 .7 3 4
7 .1 2 2 7 .2 0 0
6 .4 9 9
7 .8 1 2
9 .1 9 0
0.050
12.00
13.00
14.00
15.00
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 Minutes 18.00 20.00 22.00 24.00 26.00 28.00 30.00
8 .2 9 2
0.50
9 .1 9 4
1 0 .8 6 3 1 1 .2 3 8
9 .9 2 9
0.10
8 .2 9 2
0.050
0.40
0.30 A U
0.010
0.000
-0.010 2.00
3.00
4.00
5.00
6.00
7.00
8.00 Minutes
9.00
10.00
11.00
1 0 .9 9 2
Lot B1 99.7%
0.040
0.030
A U
0.020
9 .1 9 4
12.00
13.00
14.00
15.00
0.20
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 Minutes 18.00 20.00 22.00 24.00 26.00 28.00 30.00
1 0 .9 9 2
1 9 .6 4 0
2 0 .3 1 2
0.10
17
© 2009
Amidite Quality
Lot A2 A3 B1 Vendor A A B
31P-NMR
P NMR 96.7 98.7 99.2
vs HPLC
Solvay Organics
®
HPLC 97.1 98.5 99.7
P(III) 2.6 0.5 0.8
P(V) 0.7 0.8 0.0
18
© 2009
®
Girindus’ Manufacturing Site Cincinnati, Ohio, USA
Solvay Organics
Contract Manufacturer with strong GMP culture FDA inspected Wide range of licensing deals ensure Freedom to Operate Pre Clinical through Commercial Scale cGMP Manufacturing of Oligonucleotides 3 Manufacturing Trains available from Gram to Multi Kilogram
19
© 2009
®
Manufacturing Train 1 – Smaller Scales
AKTA 100 DNA-Synthesizer (0.1 – 8 mmol) AKTA Purifier (max. flow rate 100 mL/min) Manual Desalting system
FMI Metering Pump (1.2 L/min max flow) Total Membrane Area 0.1 – 0.4 m2
Solvay Organics
Virtis Freeze Drier (6 lyo guard trays up to 1.8 L each)
20
© 2009
AKTA 100 Oligopilot DNA/RNA
Solvay Organics
®
Synthesizer (Scale 0.1 - 8 mmoles)
21
© 2009
®
Purification - AKTA 100 Purifier (max. flow rate 100 mL/min)
Solvay Organics
22
© 2009
®
VirTis Genesis 35 XL Freeze Dryer
Solvay Organics
Space for 6 Lyoguard Freeze-Drying Trays of up to 1.8 L each Gore membrane allows for water or solvent removal without chance for spills or product contamination of freeze drier. Optional controls with vacuum gauges Barometric endpoint and moisture analysis Additional product probes and security systems. Shelf pull-down to -40°C in 30 minutes or less, with efficient, utility saving compressors.
23
© 2009
®
Manufacturing Train 2 – Mid Scale
OP 400 DNA-Synthesizer (8 – 60 mmol) Purification Systems
Bioprocess (max. flow rate 2 L/min) (low pressure) HyperSep Skid (max. flow rate 1 L/min) (high pressure)
Solvay Organics
UniFlux Automated Desalting System
10,000 mL/min max retentate flow Total Membrane Area 0.1 – 1.0 m2
Virtis Freeze Drier (12 lyo guards up to 1.8 L each)
© 2009
24
®
OligoPilotTM 400 DNA/RNA Synthesizer (Scale 8 - 60 mmoles)
Solvay Organics
25
© 2009
®
Purification
BioProcess Low Pressure System
Solvay Organics
26
© 2009
®
UniFlux 10 for HPUF Desalting
Solvay Organics
27
© 2009
®
Solvay Organics
Manufacturing Train 3 - Large Scale
Technikrom DNA-Synthesizer (10 – 120 mmol) Technikrom HPLC Skid (3 L/min max flow at 1000 PSI) Manual Desalting System
30 L/min max retentate flow Total Membrane Area 0.5 – 4.0 m2
Virtis Freeze Drier (2 x 15 lyo guards up to 1.8 L each)
28
© 2009
®
Solvay Organics
Technikrom DNA/RNA Synthesizer (Scale 20-120 mmoles) with 20 cm Dynamic Axial Compression Column
29
© 2009
®
Solvay Organics
Purification:
Technikrom HPLC Skid:
• 3 L/min max flow at 1000 PSI • Pre and post column temperature control
Varian Column
• Jacketed, 20 cm
30
© 2009
®
VirTis 50L Ultra XL-70 Freeze Dryer
Lyoguard Freeze-Drying Trays Gore membrane allows for water or solvent removal without chance for spills or product contamination of freeze drier. 15 shelves per chamber. Total of 2 chambers available. Optional controls with vacuum gauges Barometric endpoint and moisture analysis Additional product probes and security systems. Shelf pull-down to -40°C in 30 minutes or less, with efficient, utility saving compressors.
Solvay Organics
31
© 2009
© 2006 Girindus
®
Analytical Capabilities
Purity (AEX-HPLC or RP-HPLC) Purity/impurity identification LC/MS (Electrospray ionisation)
31P-NMR
Solvay Organics
Capillary Gel Electrophoresis (CGE) Water Content by Karl Fischer Coulometry Residual Solvents Endotoxins Base Composition (out-of-house) Additional out-of-house testing (sodium content, metals testing, pH measurements, bioburden)
32
© 2009
®
Summary
Girindus – Manufacturing Experience for all Major Types of Oligonucleotide Therapeutics Control of Critical Raw Materials of High Importance 3 Manufacturing Trains Available from Preclinical to Commercial Committed to Growth Full Service GMP Manufacturer
QA QC Production
Solvay Organics
FDA Inspected
33
© 2009
®
Solvay Organics
Acknowledgements
Gary Burt, Chemist, QC Analytics Jose Bonilla, Section Head, QC Analytics Wayne Davis, Production Supervisor - Oligonucleotides Tad Wyrzykiewicz, Director – Oligonucleotides
34
© 2009
© 2006 Girindus
Solvay Organics
®
®
Solvay Organics
35
© 2009
2009 35
本文档为【OligonucleotideGLOS2009】,请使用软件OFFICE或WPS软件打开。作品中的文字与图均可以修改和编辑,
图片更改请在作品中右键图片并更换,文字修改请直接点击文字进行修改,也可以新增和删除文档中的内容。
该文档来自用户分享,如有侵权行为请发邮件ishare@vip.sina.com联系网站客服,我们会及时删除。
[版权声明] 本站所有资料为用户分享产生,若发现您的权利被侵害,请联系客服邮件isharekefu@iask.cn,我们尽快处理。
本作品所展示的图片、画像、字体、音乐的版权可能需版权方额外授权,请谨慎使用。
网站提供的党政主题相关内容(国旗、国徽、党徽..)目的在于配合国家政策宣传,仅限个人学习分享使用,禁止用于任何广告和商用目的。